China Pharma Holdings (CPHI) Current Deferred Tax Assets (2010 - 2013)
China Pharma Holdings (CPHI) posted Current Deferred Tax Assets of $2.2 million for Q3 2013, up 29.88% on a QoQ basis from $1.7 million in Q2 2013, and up 223.62% year-over-year from $678297.0 in Q3 2012.
China Pharma Holdings (CPHI) Current Deferred Tax Assets (2010 - 2013) Analysis & Trends
China Pharma Holdings' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $2.2 million for Q3 2013.
- Quarterly Current Deferred Tax Assets rose 223.62% year-over-year to $2.2 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $2.2 million (up 223.62% YoY) and the FY2012 annual result came in at $967671.0, up 70.9% from the prior year.
- Current Deferred Tax Assets was $2.2 million for Q3 2013 at China Pharma Holdings, up from $1.7 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $2.2 million in Q3 2013 and bottomed at $518906.0 in Q3 2011.
- A 4-year average of $899573.5 and a median of $653266.0 in 2012 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2011 — Current Deferred Tax Assets gained 7.1% — and 2013, when it jumped 223.62%.
- China Pharma Holdings' Current Deferred Tax Assets stood at $528684.0 in 2010, then grew by 7.1% to $566226.0 in 2011, then surged by 70.9% to $967671.0 in 2012, then surged by 126.85% to $2.2 million in 2013.
- Business Quant data shows CPHI's Current Deferred Tax Assets at $2.2 million in Q3 2013, $1.7 million in Q2 2013, and $954980.0 in Q1 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 2.20 Mn |
| Sep 30, 2013 | 2.20 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Mar 31, 2013 | 954,980.00 |
| Mar 31, 2013 | 954,980.00 |
| Dec 31, 2012 | 967,671.00 |
| Dec 31, 2012 | 967,671.00 |
| Sep 30, 2012 | 678,297.00 |
| Sep 30, 2012 | 678,297.00 |
| Jun 30, 2012 | 653,266.00 |
| Jun 30, 2012 | 653,266.00 |
| Mar 31, 2012 | 617,753.00 |
| Mar 31, 2012 | 617,753.00 |
| Dec 31, 2011 | 566,226.00 |
| Dec 31, 2011 | 566,226.00 |
| Sep 30, 2011 | 518,906.00 |
| Sep 30, 2011 | 518,906.00 |
| Jun 30, 2011 | 524,290.00 |
| Jun 30, 2011 | 524,290.00 |